Literature DB >> 17500381

Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATE.

Ellen H Frankel1, Bruce E Strober, Jeffrey J Crowley, David P Fivenson, J Michael Woolley, Elaine B Yu, Hong A Xia, Chiun-Fang Chiou, Seth R Stevens.   

Abstract

Experience Diagnosing, Understanding Care, and Treatment With Etanercept (EDUCATE) is a multicenter, phase 4, 24-week, open-label study of the safety and efficacy of etanercept therapy in patients with psoriatic arthritis (PsA) in routine dermatologic practice. We present data on patient-reported outcomes (PROs) from EDUCATE, which demonstrate that subjects with PsA achieved clinically meaningful improvements in both skin- and joint-related PROs after 24 weeks of treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17500381

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

Review 1.  Etanercept: a review of its use in autoimmune inflammatory diseases.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

Review 2.  Etanercept: a review of its use in the management of ankylosing spondylitis and psoriatic arthritis.

Authors:  Sheridan M Hoy; Lesley J Scott
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis.

Authors:  Kristian Thorlund; Eric Druyts; J Antonio Aviña-Zubieta; Edward J Mills
Journal:  Biologics       Date:  2012-12-03

Review 4.  Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review.

Authors:  Sue Langham; Julia Langham; Hans-Peter Goertz; Mark Ratcliffe
Journal:  BMC Med Res Methodol       Date:  2011-03-31       Impact factor: 4.615

5.  Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study.

Authors:  Siva Narayanan; Victoria Guyatt; Alessandra Franceschetti; Emily L Hautamaki
Journal:  Psoriasis (Auckl)       Date:  2014-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.